These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

83 related items for PubMed ID: 8556611

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Intramuscular interferon beta-1a for disease progression in relapsing multiple sclerosis. The Multiple Sclerosis Collaborative Research Group (MSCRG).
    Jacobs LD, Cookfair DL, Rudick RA, Herndon RM, Richert JR, Salazar AM, Fischer JS, Goodkin DE, Granger CV, Simon JH, Alam JJ, Bartoszak DM, Bourdette DN, Braiman J, Brownscheidle CM, Coats ME, Cohan SL, Dougherty DS, Kinkel RP, Mass MK, Munschauer FE, Priore RL, Pullicino PM, Scherokman BJ, Whitham RH.
    Ann Neurol; 1996 Mar; 39(3):285-94. PubMed ID: 8602746
    [Abstract] [Full Text] [Related]

  • 4. Interferon beta induces interleukin-10 expression: relevance to multiple sclerosis.
    Rudick RA, Ransohoff RM, Peppler R, VanderBrug Medendorp S, Lehmann P, Alam J.
    Ann Neurol; 1996 Oct; 40(4):618-27. PubMed ID: 8871582
    [Abstract] [Full Text] [Related]

  • 5. [Clinical control of multiple sclerosis patients treated with interferon beta in a hospital in Peru].
    Portillo-Vallenas R, Rojas-Huerto E, Inca-Parra J.
    Rev Neurol; 1996 Oct; 41(9):575-6. PubMed ID: 16254867
    [No Abstract] [Full Text] [Related]

  • 6. Population structure and HLA DRB1 1501 in the response of subjects with multiple sclerosis to first-line treatments.
    Gross R, Healy BC, Cepok S, Chitnis T, Khoury SJ, Hemmer B, Weiner HL, Hafler DA, De Jager PL.
    J Neuroimmunol; 2011 Apr; 233(1-2):168-74. PubMed ID: 21115201
    [Abstract] [Full Text] [Related]

  • 7. Chronic myeloid leukaemia in two multiple sclerosis patients on interferon beta-1a.
    Almeida L, Neves M, Cardoso E, Melo A.
    J Clin Pharm Ther; 2009 Feb; 34(1):125-7. PubMed ID: 19125911
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Interferon beta-1B for multiple sclerosis.
    Med Lett Drugs Ther; 1993 Jul 09; 35(900):61-2. PubMed ID: 8515719
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Interferon beta-1b exacerbates multiple sclerosis with severe optic nerve and spinal cord demyelination.
    Warabi Y, Matsumoto Y, Hayashi H.
    J Neurol Sci; 2007 Jan 15; 252(1):57-61. PubMed ID: 17125797
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Interferon-beta treatment in patients with childhood-onset multiple sclerosis.
    Mikaeloff Y, Moreau T, Debouverie M, Pelletier J, Lebrun C, Gout O, Pedespan JM, Van Hulle C, Vermersch P, Ponsot G.
    J Pediatr; 2001 Sep 15; 139(3):443-6. PubMed ID: 11562627
    [Abstract] [Full Text] [Related]

  • 15. A new treatment for multiple sclerosis.
    Piascik P.
    Am Pharm; 1993 Dec 15; NS33(12):25-6. PubMed ID: 8304268
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. [10 years of interferon treatment in multiple sclerosis. Does the future belong to high-dose therapy?].
    MMW Fortschr Med; 2003 May 26; 145 Suppl 2():108. PubMed ID: 14579501
    [No Abstract] [Full Text] [Related]

  • 19. Interferon beta promotes nerve growth factor secretion early in the course of multiple sclerosis.
    Biernacki K, Antel JP, Blain M, Narayanan S, Arnold DL, Prat A.
    Arch Neurol; 2005 Apr 26; 62(4):563-8. PubMed ID: 15824253
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.